Given Pakistan’s high dependence on Indian raw material for manufacturing drugs, the government must not ban its import. Otherwise, there would be a 50 per cent loss in drug production. The situation would not only cause shortage of drugs and increase in their prices, but also weaken the country’s capability to fight Covid-19.
This warning was given by representatives of the Pakistan Pharmaceutical Manufacturers’ Association at a news conference.
Read full story here.
